Emerging technologies for cystic fibrosis transmembrane conductance regulator restoration in all people with CF.

Abstract excerpt

Although effective cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy has the potential to change the lives of many patients with cystic fibrosis (CF), it is unlikely that these drugs will be a game changing therapy for all. There are about 10% of patients with CF who don't produce a mutant protein tomodulate, potentiate, or optimize and for these patients such therapies are unlikely to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell- and Tissue-Based Therapy
• Share to Cystic Fibrosis
• Share to Cystic Fibrosis Transmembrane Conductance Regulator